D
uring the past decade, various attempts have been made to prove the efficacy of endovascular therapy in the treatment of acute ischemic stroke (AIS). Yet, it was not until 2015 that 5 large randomized clinical trials demonstrated that mechanical thrombectomy with second-generation devices substantially improves the functional outcome of patients after AIS. [1] [2] [3] [4] [5] One of the key reasons for the success of mechanical thrombectomy in the treatment for AIS is the high recanalization rate. 6 It is in this context that research in this field is rapidly expanding toward the identification of specific patient-based factors that may determine a successful revascularization. In this light, intracranial carotid artery calcification (ICAC), a highly prevalent characteristic in the middle-aged and elderly population, 7 may be of considerable importance. Apart from mechanistic difficulties that may occur during the thrombectomy procedure because of the presence and amount of ICAC that can result in a worse revascularization, ICAC may also substantially impact the prognosis after the procedure in terms of disability and mortality. Two previous studies 8, 9 have reported no association between ICAC and
Background and Purpose-Intracranial carotid artery calcification (ICAC) is a surrogate marker of intracranial arteriosclerosis, which may impact the revascularization and clinical outcome of acute stroke patients who undergo mechanical thrombectomy. Methods-We included 194 patients admitted to our Stroke Unit between January 2009 and September 2015 who underwent mechanical thrombectomy for an anterior circulation occlusion. ICAC was quantified in both intracranial carotid arteries on the nonenhanced computed tomographic scan that was acquired before thrombectomy. Complete arterial revascularization was defined as a Thrombolysis in Cerebral Infarction ≥2b on the final angiographic examination. Poor functional outcome was defined as a modified Rankin Scale score of >2 at 90 days. We assessed the independent effect of ICAC volume on complete arterial revascularization, functional outcome, and mortality using logistic regression models adjusted for relevant confounders. Against this background, we examined the relation of the burden of ICAC with arterial revascularization, functional outcome, and mortality in patients treated with mechanical thrombectomy for AIS.
Results-ICAC

Methods
Study Population
Since January 2005, we prospectively enroll all consecutive AIS patients who are treated with reperfusion therapies in our tertiary care stroke center registry (University Hospital Germans Trias I Pujol, Badalona, Spain). All patients undergo a standardized procedure at admission and are treated according to the European Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack. 10 Briefly, all patients with AIS without contraindication for intravenous thrombolysis who arrive within the first 4.5 hours after the onset of symptoms receive the standard dose of recombinant tissue-type plasminogen activator (0.9 mg/kg). Patients refractory to or ineligible for intravenous thrombolysis (including stroke onset beyond 4.5 hours, unknown onset, or wake-up stroke) are selected for endovascular treatment according to the clinical and imaging criteria (National Institutes of Health Stroke Scale [NIHSS] score of ≥6, Alberta Stroke Program Early CT score of >6, demonstration of a large vessel occlusion by computed tomographic (CT) or magnetic resonance angiography, and able to achieve groin puncture in <8 hours from onset). Multimodal imaging (magnetic resonance imaging or CT perfusion) is recommended in patients beyond 4.5 hours from stroke onset. The specific interventional modality and application of anesthesia or conscious sedation are up to the preference of the interventionalist.
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For this study, we selected all consecutive acute stroke patients with anterior circulation large artery occlusion that underwent mechanical thrombectomy between January 2009 and September 2015 (n=285). Given that since January 2009 all patients were treated with currently recommended second-generation mechanical devices, we chose this as start date for our study. This study was approved by the local Ethics Committee. Informed consent was obtained from each patient or their relatives.
Assessment of ICAC
Noncontrast cranial multidetector CT was acquired before mechanical thrombectomy and repeated 24 to 36 hours after. All CT examinations were acquired on a 16-slice Philips Brilliance scanner (Philips Healthcare, Best, The Netherlands), a 64-slice General Electric Light Speed VCT scanner (GE Medical Systems, Milwaukee, WI), or a 128-slice Philips Ingenuity scanner (Philips Healthcare). Detailed imaging parameters can be found in Table I in the online-only Data Supplement.
ICAC was measured in both intracranial carotid arteries on the nonenhanced CT examination that was made before mechanical thrombectomy. CT examinations with slice thickness >3 mm in which ICAC cannot be reliably measured were excluded from the assessment. We quantified the amount of ICAC semiautomatically using previously described, validated method. 7, 12 In short, regions of interest were manually drawn in around calcification in each consecutive CT slice in the trajectory of the intracranial carotid artery from the horizontal, petrous segment to the circle of Willis. Next, the number of pixels above a predetermined threshold of 130 Hounsfield units was calculated. This number was multiplied by the pixel size and the slice increment to obtain the volume of ICAC in mm 3 per artery. The total amount of ICAC was defined as the sum of ICAC volume in the left and right carotid arteries ( Figure 1 ). All scans were rated by 3 experienced investigators (D.B., K.P., and M.H.-P.), who were blinded for the patients clinical data. The ICAC quantification procedure took on average 5 minutes per patient. The interrater agreement was excellent (intraclass correlation coefficient based on 60 CT examinations: 0.99).
Assessment of Revascularization, Functional Outcome and Mortality
The Thrombolysis in Cerebral Infarction score was used to assess revascularization after the mechanical thrombectomy and was based on the final postprocedural angiography. Complete revascularization was defined as a Thrombolysis in Cerebral Infarction score of 2b-3. A stroke neurologist evaluated all the patients 3 months after the stroke and assessed mortality and functional outcome rated according to the modified Rankin Scale. Poor functional outcome was defined as a modified Rankin Scale score of >2. In 5 patients in whom modified Rankin Scale at that time point was not available, modified Rankin Scale at discharge was used.
Other Covariates
For all patients, we recorded demographic information and information on the following stroke risk factors using interview, physical examination, and blood sampling: smoking, hypertension, dyslipidemia, diabetes mellitus, alcohol intake, atrial fibrillation, ischemic cardiopathy, peripheral arteriopathy, and previous stroke. Stroke subtype was defined using the modified TOAST criteria (Trial of Org 10172 in Acute Stroke Treatment). 13 Also, with regard to the treatment procedure, we registered the time from groin puncture to baseline angiographic study, site of occlusion, number of passes with the device, time from onset to revascularization, and Thrombolysis 
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in Cerebral Infarction score before and after the procedure. Periprocedural complications were registered and included arterial rupture, arterial dissection, subarachnoid hemorrhage, distal embolism to unaffected artery, and unwanted detachment of the device during the intervention.
Statistical Analysis
We compared the baseline characteristics of patients included in the study with those who were not using Student t test or Mann-Whitney U test for continuous variables and χ 2 test for categorical variables. Correlations were measured with Pearson correlation coefficient. Given the skewed distribution of ICAC volume, we performed a natural log transformation after we added 1.0 mm 3 to the nontransformed values to deal with patients with a calcium score of zero (LN[calcification volume+1 mm 3 ]). We did a univariate analysis to study which variables were associated with each outcome, that is, arterial revascularization (Table II in the online-only Data Supplement), functional outcome at 3 months (Table III in the online-only Data Supplement), and mortality at 3 months (Table IV in the online-only Data Supplement). We assessed the association of ICAC volume (in the carotid artery of the symptomatic side and total volume) with revascularization, functional outcome, and mortality using logistic regression models. The multivariable analysis included age and potential risk factors that were associated with the outcomes (P≤0.1) in univariate analyses (Tables  II through IV in the online-only Data Supplement). For arterial revascularization, adjustments were made for age, site of the occlusion, cardioembolic stroke, and previous intravenous tissue-type plasminogen activator (tPA). For functional outcome, we adjusted for age, hypertension, diabetes mellitus, glycemia at admission, NIHSS at admission, arterial recanalization, and time from onset of symptoms to recanalization. And for mortality, the associations were adjusted for age, glycemia at admission, NIHSS at admission, and arterial recanalization. With regard to revascularization, we also studied the association between the amount of ICAC and the technical aspects of the thrombectomy procedure, including the impossibility of accessing the thrombus, the number of passes of the device, the occurrence of medical complications during the procedure, and the duration of the intervention. We performed 3 sensitivity analyses. First, we investigated the association of ICAC with functional outcome, after excluding patients with previous stroke (n=19). Second, we performed similar analyses while excluding those with a wake-up stroke (n=29). Third, specifically for the analyses on mortality, we handled the patients who were lost to follow-up (n=5) as dead and investigated whether this changed the results. All statistical analyses were performed with statistical software IBM SPSS Statistics 23 (Chicago, IL).
Results
In total, 285 consecutive patients with an acute stroke of the anterior circulation were treated with mechanical thrombectomy during the study period. Of these, 194 patients were included in this study. Reasons for exclusion were (1) no CT available at admission (n=34) or CT performed in other hospital (n=23), (2) severe image artifacts (n=15) or slice thickness of >3 mm (n=19), both precluding the possibility to reliably assess ICAC.
Baseline characteristics of the study population are shown in Table 1 . The mean age was 67.13 years, and 59% of the patients were men. The participants who were included in the study had a shorter interval between onset of symptoms and both time of admission and time of groin puncture (175 versus 265 minutes and 312 versus 400 minutes, respectively), and received tPA treatment more often (60.8% versus 37.4%) than excluded patients. No other differences were found between both groups. 
ICAC and Complete Arterial Revascularization
A total of 150 (77.3%) patients had a Thrombolysis in Cerebral Infarction score of 2b or 3. Patients who achieved complete arterial revascularization had lower burden of ICAC (P=0.032 for ICAC in the symptomatic artery and P=0.134 for total ICAC), had more frequent middle cerebral artery occlusion rather than ICA occlusion (P=0.003), had higher rate of cardioembolic stroke cause (P=0.010), and were more often previously treated with recombinant-tPA (P=0.002) compared with patients who did not recanalize (Table II in Table 2 ).
The amount of ICAC was not associated with difficulties during the mechanical thrombectomy, including the impossibility of accessing the thrombus, the number of passes of the device, and the occurrence of periprocedural complications (Figure 2) . Also, ICAC was not correlated with the duration of the intervention (Pearson r=−0.22; P=0.786).
We performed 2 sensitivity analyses to test whether the association between ICAC and functional outcome would change by (1) excluding from the analysis the patients with wake-up stroke and (2) excluding the patients with previous stroke. In both cases, the results did not change substantially (data not shown).
ICAC, Functional Outcome, and Mortality
Poor outcome at 3 months was found in 105 (54.1%) patients. Patients with poor outcome had larger burden of ICAC (P<0.001 for ICAC in the symptomatic artery and P=0.004 for total ICAC), were older (P=0.056), had more frequent hypertension (P=0.007) and diabetes mellitus (P=0.005), higher NIHSS score (P<0.001) and glycemia levels (P=0.010) at admission, lower rate of recanalization (P<0.001), and longer interval between stroke onset to recanalization (P=0.019) than patients who achieved good outcome at 3 months (Table  III in Table 2 ).
Three months after treatment, 25 (12.9%) subjects had died. We found that both larger ICAC volumes in the symptomatic carotid artery and total ICAC volume were associated with mortality. Other important covariates in the univariate analysis were age (P=0.041), NIHSS at baseline (P=0.1), glycemia at admission (P=0.073), and complete recanalization (P<0.0019; Table IV in the online-only Data Supplement). Adjustment for the mentioned covariates rendered the ICAC associations statistically nonsignificant (adjusted odds ratio per unit increase in ln-transformed ICAC volume: 1.36 [95% CI, 0.97-1.90] and 1.27 [95% CI, 0.93-1.74, respectively; Table 2 ). In a sensitivity analysis in which we assumed that the patients we lost to follow-up (n=5) had died, the results did not change substantially (data not shown).
Discussion
In this sample of AIS patients who underwent mechanical thrombectomy, we found that a larger burden of ICAC was associated with worse postprocedural arterial revascularization and poorer functional outcome.
According to the previous studies, a higher amount of calcium detected by nonenhanced CT in the intracranial carotid artery is related to a higher rate of luminal narrowing at that site. 14, 15 Therefore, one of the potential reasons for the association between ICAC and worse recanalization might involve mechanistic difficulties during the procedure itself. Yet, interestingly, we did not find that a larger amount of ICAC was related to a larger number of angio-interventional passes needed to extract the thrombus, access to the thrombus, a longer duration of the intervention, or more periprocedural complications. Perhaps our sample size was not big enough to detect such differences, 
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but likely other unknown mechanisms are underlying the relation between ICAC and revascularization. One potential mechanism may be that a higher degree of arterial stiffness or luminal narrowing because of large amounts of ICAC proximal to the occlusion may block the complete extraction of the thrombus. This may lead to poorer recanalization grades, yet further research is required to support this hypothesis. We also found that the ICAC load was associated with a poor functional outcome independent of recanalization status. Mechanisms underlying remain largely unknown, but it may be hypothesized that those patients with a higher burden of ICAC generally also have a worse condition of vessels more distal in the brain. 16, 17 In addition, aside from intimal calcification, calcification of the internal elastic lamina 18 also occurs relatively commonly in the intracranial part of the internal carotid artery. This arterial stiffening may directly result in increased pulse pressure leading to damage in the microvasculature and surrounding tissue. 19 Finally, during the thrombectomy procedure, passing the device through heavily calcified plaques may result in detachment of atherosclerotic material which might occlude small distal vessels leading to a poorer prognosis despite an apparent complete recanalization.
Two previous studies in smaller populations and using different therapeutical approaches did not show associations of ICAC with arterial revascularization or functional outcome. 8, 9 One explanation for this may be found in the wide variation of therapeutical approaches used in these studies. Contrary to the consistent therapy of choice in our study (second-generation devices with proven efficacy), treatments in these studies included various treatment strategies of which some were without proven efficacy in the treatment of AIS (eg, intra-arterial tPA or wire maceration). Another important difference compared with our study was the assessment of ICAC using qualitative rating scales. Although we acknowledge some drawbacks of this quantitative method (mainly its time-consuming nature), an interesting notion is that not only total burden of ICAC but also ICAC in the symptomatic carotid artery was markedly associated with recanalization and functional outcome. This suggests that assessment of the amount of ICAC on the symptomatic side only may be enough to get an impression on the prognosis after the thrombectomy procedure. Alternatively, when applied in the acute clinical setting, quick assessment using the (modified) Woodcock scale 20 might also be valuable. In this visual scoring, a number from 0 (no calcification) to 3 (thick, continuous calcification) is assigned to the severity of calcification on each axial slice. Then, the assigned numbers are summed to create a total score for each carotid artery. The clinical value of this method should be further evaluated in future research.
Strengths of our study include the standardized assessment of patient inclusion, the consistent use of the same treatment strategy, and the quantitative approach of ICAC assessment. Yet, some considerations with regard to our study should also be addressed. First, our study was conducted retrospectively. However, all patient data have been collected in a prospective manner, and an accurate description of included and excluded population was provided. Second, we found that excluded patients experienced a longer time from stroke onset to admission. This may explain the smaller rate of patients treated with tPA and the greater delay between onset and groin puncture in this group. Other than this, there were no differences between included and excluded patients, suggesting that our population is representative of the common acute stroke population.
Third, our sample was recruited during a 6-year period during which bridging with mechanical thrombectomy after intravenous tPA was not yet the standard of care, and stent retriever thrombectomy was only considered in patients refractory or ineligible for intravenous fibrinolysis. In this way, our results refer to a group of patients with thrombus resistance to intravenous tPA revascularization, and generalizability to the bridging lysis collective is limited.
In conclusion, our study shows that the amount of ICAC before mechanical thrombectomy in AIS patients is a marker of worse postprocedural arterial revascularization and poor functional outcome.
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